AJANTA PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Quarterly Results    (AJPH)

Here are the latest quarterly results of AJANTA PHARMA. For more details, see the AJANTA PHARMA financial fact sheet and AJANTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

AJANTA PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m5,1105,4414,8515,1526,1196,4286,5126,820 
Other income Rs m81152441676132146567 
Turnover Rs m5,1915,5944,8955,1686,1966,5606,6597,387 
Expenses Rs m3,5353,7793,7783,8814,4364,6514,6525,306 
Gross profit Rs m1,5751,6621,0731,2711,6841,7661,8561,488 
Depreciation Rs m172175187188228233236260 
Interest Rs m211818491636 
Profit before tax Rs m1,4831,6389301,0921,5151,6161,7511,759 
Tax Rs m425385261203368452676467 
Profit after tax Rs m1,0581,2546698891,1461,1641,0761,292 
Gross profit margin %30.830.522.124.727.527.528.521.8 
Effective tax rate %28.723.528.018.624.328.038.626.6 
Net profit margin %20.723.013.817.318.718.116.518.9 
Diluted EPS Rs 12.0 14.3 7.6 10.1 13.0 13.2 12.2 14.7  
Diluted EPS (TTM) Rs 54.5 53.8 44.6 44.0 45.0 44.0 48.6 53.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: AJANTA PHARMA 4QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   NOVARTIS  IPCA LABS  DR. REDDYS LAB  PROCTER & GAMBLE HEALTH  INDRAPRASTHA MEDICAL  

Compare AJANTA PHARMA With:   NOVARTIS  IPCA LABS  DR. REDDYS LAB  PROCTER & GAMBLE HEALTH  INDRAPRASTHA MEDICAL  

Compare AJANTA PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Tata Steel & ONGC Top Gainers(12:30 pm)

Share markets in India are presently trading marginally higher, tracking positive global sentiments.

Views on news

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World (Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade? (Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jun 5, 2020 12:29 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA - MYLAN COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS